Results
|
2201.
|
|
|
2202.
|
|
|
2203.
|
|
|
2204.
|
FcγR interaction is not required for effective anti-PD-L1 immunotherapy but can add additional benefit depending on the tumor model. [electronic resource] by
- Sow, Heng Sheng
- Benonisson, Hreinn
- Breukel, Cor
- Visser, Remco
- Verhagen, Onno J H M
- Bentlage, Arthur E H
- Brouwers, Conny
- Claassens, Jill W C
- Linssen, Margot M
- Camps, Marcel
- van Hall, Thorbald
- Ossendorp, Ferry
- Fransen, Marieke F
- Vidarsson, Gestur
- Verbeek, J Sjef
Producer: 20190405
In:
International journal of cancer vol. 144
Availability: No items available.
|
|
2205.
|
|
|
2206.
|
Clinical Significance of PD-L1 Expression in Both Cancer and Stroma Cells of Cholangiocarcinoma Patients. [electronic resource] by
- Kitano, Yuki
- Yamashita, Yo-Ichi
- Nakao, Yosuke
- Itoyama, Rumi
- Yusa, Toshihiko
- Umezaki, Naoki
- Tsukamoto, Masayo
- Yamao, Takanobu
- Miyata, Tatsunori
- Nakagawa, Shigeki
- Okabe, Hirohisa
- Imai, Katsunori
- Chikamoto, Akira
- Ishiko, Takatoshi
- Baba, Hideo
Producer: 20200929
In:
Annals of surgical oncology vol. 27
Availability: No items available.
|
|
2207.
|
Aggregable Nanoparticles-Enabled Chemotherapy and Autophagy Inhibition Combined with Anti-PD-L1 Antibody for Improved Glioma Treatment. [electronic resource] by
- Ruan, Shaobo
- Xie, Rou
- Qin, Lin
- Yu, Meinan
- Xiao, Wei
- Hu, Chuan
- Yu, Wenqi
- Qian, Zhiyong
- Ouyang, Liang
- He, Qin
- Gao, Huile
Producer: 20200730
In:
Nano letters vol. 19
Availability: No items available.
|
|
2208.
|
|
|
2209.
|
|
|
2210.
|
|
|
2211.
|
|
|
2212.
|
|
|
2213.
|
|
|
2214.
|
|
|
2215.
|
|
|
2216.
|
|
|
2217.
|
|
|
2218.
|
PD-L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapy. [electronic resource] by
- Azad, Abul
- Yin Lim, Su
- D'Costa, Zenobia
- Jones, Keaton
- Diana, Angela
- Sansom, Owen J
- Kruger, Philipp
- Liu, Stanley
- McKenna, W Gillies
- Dushek, Omer
- Muschel, Ruth J
- Fokas, Emmanouil
Producer: 20170926
In:
EMBO molecular medicine vol. 9
Availability: No items available.
|
|
2219.
|
|
|
2220.
|
Stat3 inhibitor abrogates the expression of PD-1 ligands on lymphoma cell lines. [electronic resource] by
- Ma, Chaoya
- Horlad, Hasita
- Pan, Cheng
- Yano, Hiromu
- Ohnishi, Koji
- Fujiwara, Yukio
- Matsuoka, Masao
- Lee, Aeju
- Niidome, Takuro
- Yamanaka, Ryuya
- Takeya, Motohiro
- Komohara, Yoshihiro
Producer: 20171009
In:
Journal of clinical and experimental hematopathology : JCEH vol. 57
Availability: No items available.
|